National Hepatitis C Testing Policy May 2007

Appendix 2 Stakeholder consultation

Page last updated: July 2007

The following stakeholders were provided with a consultation draft of this document for comment:

Australia:

Aboriginal Health and Medical Council (NSW)

Australasian Professional Society on Alcohol and Other Drugs

Australasian Society for HIV Medicine

Australian Association of Pathology Practices

Australian Centre in Hepatitis and HIV Virology Research

Australian Divisions of General Practice

Australian Injecting and Illicit Drug Users’ League

Australian Liver Association

Australian Red Cross Blood Service

Australian Society for Infectious Diseases

Blood Borne Virus and Sexually Transmissible Infections Subcommittee (BBVSS) of the Australian Population Health Development Principle Committee (APHDPC)

Communicable Diseases Network Australia

Gastroenterological Society of Australia

Haemophilia Foundation Australia

HIV/AIDS and STIs Subcommittee of MACASHH

Indigenous Australians’ Sexual Health Committee of MACASHH

Medical Industry Association of Australia

National Association of Testing Authorities, Australia

National Coalition of Public Pathology

National Pathology Accreditation Advisory Council

National Serology Reference Laboratory, Australia

Public Health Association

Public Health Laboratory Network

Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Royal Australian College of General Practitioners

Royal Australasian College of Physicians

Royal Australian College of Surgeons

Royal College of Pathologists of Australasia

RCPA QAP Pty Ltd (Serology QAP)

Turning Point Alcohol and Drug Centre

Transplantation Society of Australia and New Zealand

Therapeutic Goods Administration

New Zealand:

Ministry of Health

New Zealand Hepatitis Foundation